Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biohit Oyj Board/Management Information 2018

Oct 16, 2018

3304_rns_2018-10-16_f4b54eb9-1dca-473b-b2f3-b20057a6aeba.html

Board/Management Information

Open in viewer

Opens in your device viewer

Stina Syrjänen resigns from Biohit Oyj’s Board of Directors

Stina Syrjänen resigns from Biohit Oyj’s Board of Directors

Biohit Oyj 16.10.2018 12:20 local time

*Stina Syrjänen resigns from Biohit Oyj’s Board of Directors*

Stina Syrjänen has notified Biohit Oyj that she will resign from the company’s Board of Directors. The resignation is effective immediately.

The Board of Directors of Biohit Oyj will continue to operate with five members as a new member was elected at the Extraordinary Shareholders' Meeting on the 16th of August 2018.

Additional information:

CEO Semi Korpela, Biohit Oyj

tel. +358 9 773 861

[email protected]

www.biohithealthcare.com

Biohit Oyj in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission ‘Innovating for Health’ means that we provide innovative products and services to promote research and early diagnostics. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s B series shares (BIOBV) are quoted on NASDAQ OMX Helsinki under Small cap/Healthcare. www.biohithealthcare.com